BIOMEDevice: Leukocare’s Postcoating Stabilisation Technology Preserves Biomolecular Functionality
Sunday, February 7th, 2010Think of it as the confection that holds together a fruitcake. That is how Michael Scholl, CEO of Leukocare, described his company’s surface functionalisation and binding technology to BIOMEDevice Europe attendees. It was one of several papers presented under the thematic umbrella of Enabling Technologies for Manufacturing Combination Products at ...
